T-O (am): 0.000 (08:59:00)
Last updated: 16:52
Customize
Select columns required and click "Update" to save your preferences
Ann. Date | Qtr. Date | Q | FYE | Revenue [M] | PBT [M] | NP [M] | NPM | DPS | EPS | R. QoQ | R. YoY | E. QoQ | E. YoY | TTM EPS |
Adj. [M] |
NP [M] (adj) |
NPM (adj) |
EPS (adj) |
E. QoQ (adj) |
E. YoY (adj) |
TTM EPS (adj) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
17 Jul 24 | Q4 May 24 | 4 | 31 May 24 | 46.74 | 19.42 | 14.01 | 30.0% | 0.00 | 0.29 | 14.8% | 3.1% | ||||||||||
16 Apr 24 | Q3 Feb 24 | 3 | 31 May 24 | 40.70 | 18.01 | 13.59 | 33.4% | 0.49 | 0.30 | 5.6% | 11.2% | ||||||||||
18 Mar 24 | Q2 Nov 23 | 2 | 31 May 24 | 38.54 | 16.64 | 12.21 | 31.7% | 0.21 | 0.27 |
EPS | 1.09 sen |
Trailing PE (Sector Median: 25.3) | 32.1 |
PEG | 10.35 |
Altman Z | 4.9 |
Beaver | 1.108 |
Current Ratio | 2.92 |
Debt-Equity (DE) Ratio | 0.63 |
FCF Yield | 1.99 % |
Revenue QoQ | 14.84 % |
Revenue YoY | 0% |
Profit QoQ | 3.1 % |
Profit YoY | 0 % |
Profit Margin (Sector Median: 9.2) | 31.59 % |
ROE (ROIC: 88.79) | 88.79 % |
Dividend Per Share (DPS) | 0.7 sen |
Dividend Yield (DY) | 2.0 % |
Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports
EPS | |
Trailing PE (Sector Median: 25.3) | |
Profit QoQ | |
Profit YoY | |
Profit Margin (Sector Median: 9.2) | |
ROE (ROIC: 88.82) | |
Altman Z |
Discounted Cash Flow (DCF) 5% Growth | |
Discounted Cash Flow (DCF) 10% Growth | |
Relative Valuation | |
Average Analysts FV based on 4 rating(s) |
Graham Formula | |
Graham Number | |
Net Tangible Asset (NTA) | 0.04 | Consistent QR FV |
Forward PE FV Calculator | |
Latest Profit (adjusted) [M] | 14.01 |
Expected Profit (Next QR) [M] | |
Expected Profit (After QR above) [M] | |
Expected Profit (After QR above) [M] | |
Estimated Fair Value |
Growth/Risk Fair Value Calculator | |
Expected growth (%) | |
Estimated downside / risk (%) | |
Estimated New DCF Fair Value |
Contract/Award Contribution Calculator | |
Contract/Award Value (in Million) | |
Estimated Contribution to Stock Price | |
Estimated New DCF Fair Value |
Profit-Based Calculator | |
Expected Profit (M) | |
for Year | |
Estimated New DCF Fair Value |
Revenue-Based Calculator | |
Expected Revenue (M) | |
for Year | |
Estimated New DCF Fair Value |
Market Pricing | |
Expected Profit (M) | 0 |
Expected Revenue (M) | 0 |
Expected Growth (%) | 0 |
No transaction in the last 2 months.
Market Cap: 1701 M.
Number of Shares: 4860 M.
Adjusted Float: 0%.
Alpha IVF is an investment holding company. Through its subsidiaries, Alpha IVF are primarily a fertility care specialist focusing on the provision of assisted reproductive services in Malaysia and Singapore. Alpha have two specialist centres in Malaysia and one specialist centre in Singapore which focuses on in-vitro fertilisation (IVF) services. In addition, Alpha IVF provide other assisted reproductive procedures including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), various diagnostics, testing and screening procedures as well as cryopreservation of eggs, sperms and embryos to support our assisted reproductive services.
Sectors: Healthcare, Health Care Providers, Penny Stocks
Code: 0303
Website: http://www.alphaivfgroup.com
Related Links: Bursa | Annual Report | Announcement
No warrants listed
Shareholder | % | Value (M) |
---|---|---|
Dato' Dr Lee Soon Soo | 34.25% | 582.63 |
Ace Specialists Sdn Bhd | 9.15% | 155.69 |
Madam Lee Soon Ai | 8.91% | 151.63 |
Dr Ng Peng Wah | 8.32% | 141.49 |
Dr Leong Wai Yew | 6.58% | 111.87 |
Datuk Lee Say Tshin | 0.07% | 1.17 |
Madam Sia Bee Keng | 0.01% | 0.24 |
Dato Dr Tan Kee Kwong | 0.01% | 0.17 |
Tung Fook Heng | 0.01% | 0.1 |